Dettaglio modulo

Omics in Oncology

MS2131

Insegnamento
Omics in Oncology
Codice
MS2131
Anno Accademico
2024/2025
Anno regolamento
2023/2024
Corso di studio
MEDICAL BIOTECHNOLOGY
Curriculum
A006 - SYSTEM BIOMEDICINE
Responsabile didattico
CFU
5
Ore di lezione
30
Settore Scientifico Disciplinare (SSD)
MED/06 - ONCOLOGIA MEDICA
Tipo di insegnamento
Attività formativa monodisciplinare
Fruizione insegnamento
OBB - Obbligatoria
Anno
2
Periodo
Secondo Semestre
Sede
NOVARA
Lingua insegnamento
Inglese
Contenuti
The course is focused on a comprehensive overview of the clinical utility of multi-omics in tumor classifications, prognostications, diagnostics, and the role of data integration in the search for novel biomarkers and therapeutic opportunities. Extensive analysis of the currently used classificators will be detailed.
Testi di riferimento
Powerpoint slide presentation
Scientific articles
Obiettivi formativi
To provide the students with elements of knowledge relating to the most important oncological pathologies with particular reference to the themes of the multiomics approach in the diagnosis and treatment and also according to currently available targeted agents.
Metodi didattici
Powerpoint slide presentation
Scientific articles
Modalità di verifica dell'apprendimento
Written elaborate: multiple statements to be commented
Programma esteso
The principles of personalised medicine in oncology will be presented,
including also the different therapeutic opportunities by tumor type and
different subtypes of the same tumors. The development of the most
used targeted agents will be discussed. The different “omic” techniques
will be explained.
Risultati di apprendimento attesi
The student is expected to be able to identify the best molecular approach
for the different tumor types and to understand the impact of the
personalised "omic" approach in cancer medicine.
Ultimo aggiornamento:09-09-2026 00:14:31